Anti-LIPC Antibody

Raised in rabbits against the LIPC target, this polyclonal primary antibody recognizes human hepatic lipase, a liver-expressed enzyme that hydrolyzes triglycerides and phospholipids during plasma lipoprotein remodeling. The unconjugated reagent is supplied at 1 mg/ml in PBS with 0.1% sodium azide and 50% glycerol, and ships ready to dilute into standard immunolabeling workflows. Manufacturer-validated applications include Western blot (WB), immunohistochemistry (IHC), and immunofluorescence (IF), allowing the same lot to be used for lysate-based detection, fixed-tissue localization, and subcellular imaging of LIPC in hepatic and hepatocyte-derived samples. The 100 µl pack size is well matched to exploratory screens and pilot studies, where multiple blots or section sets are processed before committing to larger reagent volumes. Because the antibody is polyclonal, it recognizes multiple epitopes and is more tolerant of partial protein degradation than a monoclonal reagent, an advantage when working with archived or variably preserved material. Researchers investigating HDL metabolism, hepatic lipid handling, or cardiovascular risk loci near LIPC benefit from reactivity matched to human antigen, while the unconjugated format allows the user to couple the antibody to any reporter of choice, including HRP, biotin, or fluorophores. For storage, keep the glycerol formulation at -20 °C, avoid repeated freeze-thaw cycles, and aliquot on first use to preserve binding activity across long projects. As supplied by Antibodies.com, the reagent is intended for research use only and is not validated for diagnostic or therapeutic procedures.